Begelomab (Anti-DPP4 / CD26)
Begelomab (Anti-DPP4 / CD26) is a monoclonal antibody targeting DPP-4/CD26. Begelomab can be used for the research of severe refractory idiopathic inflammatory myopathy. MW: 145.5 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2517 |
Sku # | A2517-1mg*25 |
Pricing | 1mg*25, $5070.00 |